Qube Research & Technologies Ltd
Position in TBPH — Theravance Biopharma, Inc.
CIK 1729829
LONDON, X0
Position in TBPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,306,821
+$2,608,675 QoQ
Shares Held
429,813
+48.5% QoQ
Ownership
0.828%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 179 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. TBPH ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | 659,678 | $87,559,060 | |||
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in TBPH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,306,821 | 429,813 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,698,146 | 289,473 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,859,147 | 473,498 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,081,300 | 211,048 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,264,238 | 205,280 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,017,475 | 113,939 | Shares | Sole | 2025-05-15 | |
| 2020-09-30 | $252,734 | 17,094 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $275,451 | 13,123 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||